Roland Walter, MD
Hematology · Seattle, WANPI 1124139738
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $77,166 of the $92,221 with a category attached, or 83.7%. It is spread thinly across 15 manufacturers, the largest accounting for just 14.8%. Among hematology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 77 payments — averaging $1197.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$14K
- AbbVie$13K
- Agios Pharmaceuticals, Inc.$10K
- Janssen Global Services, LLC$9K
- Amgen$8K
- Bristol Myers Squibb$6K
- plus $32K from 9 others
Across 262 payments — averaging $46,302 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$2.6M
- Bristol Myers Squibb$2.6M
- Pfizer$2.2M
- Janssen Research & Development, LLC$2M
- AbbVie$1.6M
- Amgen$415K
- plus $677K from 5 others
What the payments were for
- Consulting fees$77,16684%
- Speaking & faculty fees$9,44410%
- Travel & lodging$3,3564%
- Food & beverage$2,2552%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 7 | $13,650 |
| AbbVie | 10 | $13,454 |
| Agios Pharmaceuticals, Inc. | 16 | $9,901 |
| Janssen Global Services, LLC | 7 | $9,322 |
| Amgen | 10 | $8,102 |
| Bristol Myers Squibb | 5 | $5,760 |
| Astellas Pharma US Inc | 6 | $5,507 |
| E.r. Squibb & Sons, L.L.C. | 3 | $4,968 |
| Jazz Pharmaceuticals Inc. | 2 | $4,500 |
| Pfizer | 2 | $4,325 |
| Gilead(2 entities) | 2 | $3,140 |
| Syndax Pharmaceuticals, Inc. | 3 | $3,079 |
| Stemline Therapeutics Inc. | 1 | $2,925 |
| Astrazeneca UK Limited | 2 | $1,938 |
| Genentech USA, Inc. | 1 | $1,650 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$92,221 in reported general payments places this provider in the 90th percentile of 43 hematology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Seattle
- Barbara KonkleSeattle$250K
- Terry GernsheimerSeattle$148K
- Sandhya PanchSeattle$140K
- Cecilia YeungSeattle$42K
- Kleber Yotsumoto FertrinSeattle$29K
- Jordan GauthierSeattle$17K
- David NgSeattle$9K
- Jose LopezSeattle$8K
- Geoffrey HillSeattle$8K
- Arthur ThompsonSeattle$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.